{"id":89419,"date":"2025-10-30T11:08:48","date_gmt":"2025-10-30T10:08:48","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=89419"},"modified":"2026-05-29T23:09:11","modified_gmt":"2026-05-29T21:09:11","slug":"top-20-biopharma-leaders-on-why-they-chose-vault-crm-4-case-studies-in-commercial-excellence","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/top-20-biopharma-leaders-on-why-they-chose-vault-crm-4-case-studies-in-commercial-excellence\/","title":{"rendered":"Top 20 Biopharma Leaders on Why They Chose Vault CRM: 4 Case Studies in Commercial Excellence"},"content":{"rendered":"<p><a href=\"\/eu\/products\/crm-suite\/\">³Ô¹Ï±¬ÁÏ Vault CRM<\/a>, a deep application for commercial biopharma, delivers meaningful and compliant customer engagement across all channels. Over 100 biopharmas \u2014 including the top 20 global leaders featured here \u2014 have adopted Vault CRM. Their choice defines a long-term strategy for engaging a complex customer universe and delivering transformative therapies.<\/p>\n<p>While different strategies drove their decisions, these leaders all selected ³Ô¹Ï±¬ÁÏ as a proven partner on the Industry Cloud for Life Sciences. They gain a connected, data-first approach to stay customer-focused, using <a href=\"\/eu\/products\/veeva-ai\/\">AI in Vault CRM<\/a>, orchestration, and dynamic targeting within the Vault Platform to eliminate distraction and hype. <\/p>\n<h2>Key drivers for choosing Vault CRM: connectivity and patient focus<\/h2>\n<p>Breaking through to healthcare professionals (HCPs) contending with high volumes of scientific information across channels is a common challenge. The stakes are higher with more acute disease states, increasing therapeutic complexity, and shorter launch windows.<\/p>\n<p>Data shows that medical and commercial teams working together provide a connected flow of personalized data and content to customers efficiently to get medicines to patients faster.<sup>1<\/sup> Yet, 65% of HCP engagements with biopharmas remain unsynchronized.<sup>2<\/sup><\/p>\n<p>In the world of specialized medicine, the featured biopharma leaders and many others have empowered complex field teams to work together. Their territory managers, account managers, medical and other specialists \u2014 along with marketing, inside sales, and customer service teams \u2014 are set up to be unified and customer-centric by default.<\/p>\n<p>Other commonalities among these companies include:<\/p>\n<ul>\n<li><strong>Preparing for major launches<\/strong>: Many are in a launch-heavy phase, relying on their CRM to innovate ahead of the curve and establish scalable processes for launch excellence. <\/li>\n<li><strong>Minimizing risk<\/strong>: They agree it\u2019s crucial to get technology decisions right the first time to avoid unnecessary risk, customizations, or restarts if a vendor\u2019s focus changes.<\/li>\n<li><strong>Seeking industry-specific AI<\/strong>: All seek the fastest path to scalable, agentic AI embedded in their core applications, supported by a partner who can ensure <a href=\"\/eu\/services\/business-consulting-services\/\">successful adoption<\/a>.<\/li>\n<li><strong>Expecting zero business disruption<\/strong>: These leaders count on their vendors to manage technology rollouts without distracting from their core focus on customers and patients.<\/li>\n<\/ul>\n<p>Four top biopharmas reflect on Vault CRM\u2019s advantages, sharing how the solution is helping sales, marketing, and medical teams advance commercial excellence and meet patients\u2019 rapidly changing therapeutic needs.<\/p>\n<h2>Novo Nordisk: Driving innovation and growth with Vault CRM<\/h2>\n<p>Novo Nordisk is perhaps best known for mainstream obesity and diabetes medicines. However, the company is committed to expanding into new disease areas with unmet patient needs. Time is of the essence in delivering deep scientific information and resources to historical customers while engaging new ones.<\/p>\n<p>\u201cIt&#8217;s important to seize opportunities to be at the forefront to benefit patients. I\u2019ve seen companies wait for \u2018one more feature\u2019 and never move. We want to ensure, as we move into our next 100 years, that our software is cutting edge,\u201d says Frank Armenante, field systems director for Novo Nordisk. With ³Ô¹Ï±¬ÁÏ as its partner, Armenante says the company will gain value through efficiencies and increased productivity while experiencing \u2018rapid guided innovation.\u2019<\/p>\n<p>His team supports all business units across sales, marketing, medical, and market access. In migration planning they offered a menu of the innovation in Vault CRM and discussed what matters most to each unit. Industry-specific AI embedded in the shared platform will connect teams to more efficiently reach customers and patients, and Armenante says his team looks forward to using AI in Vault CRM for improved engagement planning and productivity.<\/p>\n<p>Agentic Call Report&trade; generates a prioritized list of customers to interact with based on multiple factors, including adoption by indication, activity versus potential, previous and new activities, and other information captured. Agentic Voice will drive significant productivity gains and allow the field to focus on what he calls the value parts of their jobs \u2014 customer touchpoints.<\/p>\n<p>He sees <a href=\"\/eu\/products\/crm-suite\/\">Service Center<\/a> as another way to give customer-facing teams an edge, accessing data fast, working in the ways they prefer, and strategizing with the home office to deliver a customer-centric experience. This application in Vault CRM Suite ensures field teams work from the same customer data, content, and processes.<\/p>\n<p>\u201cYou\u2019ve got to have software that\u2019s ahead of the curve. That\u2019s what\u2019s going to allow you to be innovative, thoughtful, a good partner \u2014 and do good for the world,\u201d Armenante says. <\/p>\n<div class=\"leading-quote leading-quote--inline leading-quote--inline-in-content\">\n<div class=\"leading-quote__inner\">\n<p>&#8220;The decision to switch to Vault CRM was driven by the desire for the most innovative technology and a flexible partner, both of which ³Ô¹Ï±¬ÁÏ delivers on.&#8221;<\/p>\n<div class=\"content-leading-quote__author\">\n<h6>Frank Armenante<\/h6>\n<p>Director, Field Systems, Novo Nordisk<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p><strong>Watch now<\/strong>: See how Novo Nordisk plans to innovate and grow with ³Ô¹Ï±¬ÁÏ Vault CRM.<\/p>\n<script>\n\t\t\twindow._wq = window._wq || [];\n\t\t\t_wq.push({\n\t\t\t  id: \"6jj6fqdhpy\",\n\t\t\t  options: {\n\t\t\t\tplugin: {\n\t\t\t\t  \"captions\": {\n\t\t\t\t\tonByDefault: true,\n\t\t\t\t\tlanguage: \"ang\" \/\/ ang - English, fre - French, ger - German, ita - Italian, spa - Spanish\n\t\t\t\t  }\n\t\t\t\t}\n\t\t\t  }\n\t\t\t});\n\t\t\t<\/script><script src=\"https:\/\/fast.wistia.com\/embed\/medias\/6jj6fqdhpy.jsonp\" async><\/script><script src=\"https:\/\/fast.wistia.com\/assets\/external\/E-v1.js\" async><\/script><div class=\"wistia_responsive_padding\" style=\"padding:56.25% 0 0 0;position:relative;\"><div class=\"wistia_responsive_wrapper\" style=\"height:100%;left:0;position:absolute;top:0;width:100%;\"><div class=\"wistia_embed wistia_async_6jj6fqdhpy videoFoam=true\" style=\"height:100%;position:relative;width:100%\"><div class=\"wistia_swatch\" style=\"height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;\"><img decoding=\"async\" src=\"https:\/\/fast.wistia.com\/embed\/medias\/6jj6fqdhpy\/swatch\" style=\"filter:blur(5px);height:100%;object-fit:contain;width:100%;\" alt=\"\" aria-hidden=\"true\" onload=\"this.parentNode.style.opacity=1;\" \/><\/div><\/div><\/div><\/div>\n<h2>Boehringer Ingelheim sets the foundation for 20 launches in 20 years<\/h2>\n<p>A connected customer engagement model uses the strength of unified teams and technology to benefit stakeholders in biopharma. Sales, marketing, and medical teams working in harmony deliver deep scientific information more efficiently and improve patient adoption of vital new medicines.<\/p>\n<p>\u201cDelivering outstanding customer experiences and accelerating launch processes were catalysts for us in thinking about connected engagement,\u201d says Dee-Dee Van Wormer, Boehringer Ingelheim\u2019s senior associate director of customer facing effectiveness. The company is a top 20 biopharma committed to Vault CRM, a key part of its strategy to reach more patients in need.<\/p>\n<p>While Boehringer Ingelheim maintains a strong presence in diabetes, heart disease, and other broad treatment areas, it\u2019s preparing to launch 20 therapeutics over the next 20 years in new and rare disease areas with unmet patient needs. Vault CRM will help accelerate product launches by streamlining processes and enhancing customer experiences.<\/p>\n<p>A connected customer engagement model has created a new approach to strategic account management for Boehringer Ingelheim, boosting field force efficiency and driving deeper understanding of customer needs, Van Wormer says. \u201cWe asked, \u2018What behaviors do we want to enable and encourage?\u2019 <a href=\"\/eu\/services\/business-consulting-services\/\">³Ô¹Ï±¬ÁÏ Business Consulting<\/a> helped us shape the operating model. The project focused on ensuring our technology would facilitate teaming and sharing of insights, as well as speed adoption of the tools and data.\u201d<\/p>\n<p>The company is prepared to benefit from upcoming AI innovation in Vault CRM, allowing for even richer and smoother teaming. With the ability to quickly surface insights and content informed by prior customer interactions, field teams can supercharge their existing edge. An example is Agentic Voice, which allows users to control the CRM with their voice to compliantly record and auto-transcribe call notes from any device or location.<\/p>\n<p>\u201cI was a representative in the field and thought many times, \u2018Wouldn&#8217;t it be cool to press a button and capture notes?\u2019 Our field teams will be able to log customer call notes and assign a task to teammates in minutes,\u201d she says. Sales, marketing, and medical will rapidly know what was discussed with a customer so they can plan for their next interaction. As Boehringer Ingelheim\u2019s users enter voice or typed notes, <a href=\"\/eu\/resources\/veeva-ai-for-vault-crm\/\">AI<\/a> in Vault CRM auto-checks for compliance in real time and flags statements or phrases that require follow-up.<\/p>\n<p>Next, Boehringer Ingelheim seeks to expand on its existing ³Ô¹Ï±¬ÁÏ Commercial Cloud solutions and One Medicine and Amplify platforms, which connect development processes and data on ³Ô¹Ï±¬ÁÏ Development Cloud. <\/p>\n<div class=\"leading-quote leading-quote--inline leading-quote--inline-in-content\">\n<div class=\"leading-quote__inner\">\n<p>&#8220;The project focused on ensuring our technology would facilitate teaming and sharing of insights, as well as speed adoption of the tools and data.&#8221;<\/p>\n<div class=\"content-leading-quote__author\">\n<h6>Dee-Dee Van Wormer<\/h6>\n<p>Senior Associate Director of Customer Facing Effectiveness, Boehringer Ingelheim<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p><strong>Watch the chat<\/strong>: Discover Boehringer Ingelheim\u2019s strategy for connected customer engagement.<\/p>\n<script>\n\t\t\twindow._wq = window._wq || [];\n\t\t\t_wq.push({\n\t\t\t  id: \"vywq9saday\",\n\t\t\t  options: {\n\t\t\t\tplugin: {\n\t\t\t\t  \"captions\": {\n\t\t\t\t\tonByDefault: true,\n\t\t\t\t\tlanguage: \"ang\" \/\/ ang - English, fre - French, ger - German, ita - Italian, spa - Spanish\n\t\t\t\t  }\n\t\t\t\t}\n\t\t\t  }\n\t\t\t});\n\t\t\t<\/script><script src=\"https:\/\/fast.wistia.com\/embed\/medias\/vywq9saday.jsonp\" async><\/script><script src=\"https:\/\/fast.wistia.com\/assets\/external\/E-v1.js\" async><\/script><div class=\"wistia_responsive_padding\" style=\"padding:56.25% 0 0 0;position:relative;\"><div class=\"wistia_responsive_wrapper\" style=\"height:100%;left:0;position:absolute;top:0;width:100%;\"><div class=\"wistia_embed wistia_async_vywq9saday videoFoam=true\" style=\"height:100%;position:relative;width:100%\"><div class=\"wistia_swatch\" style=\"height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;\"><img decoding=\"async\" src=\"https:\/\/fast.wistia.com\/embed\/medias\/vywq9saday\/swatch\" style=\"filter:blur(5px);height:100%;object-fit:contain;width:100%;\" alt=\"\" aria-hidden=\"true\" onload=\"this.parentNode.style.opacity=1;\" \/><\/div><\/div><\/div><\/div>\n<h2>GSK migrates to Vault CRM to innovate: Early-mover advantage with AI <\/h2>\n<p>GSK\u2019s plans to migrate to Vault CRM began almost immediately after ³Ô¹Ï±¬ÁÏ\u2019s announcement. \u201cAt GSK, we put data and technology at the core in achieving our goal to positively impact 2.5 billion lives by 2030. Based on ³Ô¹Ï±¬ÁÏ\u2019s deep life science expertise, we voiced our intent to be the first large pharma company to migrate to Vault CRM. It represents a strategic next step for us,\u201d says Sujatha Chinnappa, global vice president, commercial technology, engineering, and data at GSK.<\/p>\n<p>GSK has an ambitious agenda to move forward on its AI journey. As a result, the team views the migration not just as a platform upgrade, but as the best way to unlock the next generation of AI-driven engagements and decisions. \u201cBeing an early adopter of Vault CRM migration enables us to use AI in Vault CRM sooner \u2014 and bring our own agents,\u201d Chinnappa says. This migration sets the foundation by deeply embedding AI in their enterprise system, rather than treating it as an afterthought.<\/p>\n<p>Chinnappa thinks of the CRM as a nervous system linking other business critical applications and data lakes, so she says it\u2019s never too early to start thinking about integrations. It took time upfront for GSK and ³Ô¹Ï±¬ÁÏ to consider architecture and design, determining the best way to migrate and performing tech remediation and data cleanup as prework. \u201cWith the great partnership between GSK and ³Ô¹Ï±¬ÁÏ, we were able to work through any issues and are on track to deliver on the ambitious migration schedule we set at the beginning,\u201d she says.<\/p>\n<p>Last but not least are change management considerations. GSK conducts change impact assessments by persona and creates user training as part of the core migration plan for success. For example, field representatives are in the company\u2019s \u2018no change impact\u2019 category, while administrator roles such as key account managers are grouped in a \u2018medium to high impact\u2019 category that receives upskilling and training.<\/p>\n<p>With the company\u2019s migration process on schedule, more than 18,000 users in 50+ countries are expected to be live by the year\u2019s end. GSK\u2019s early migration is allowing the company to concentrate on its strategic priorities. \u201cMy team has spent zero hours running CRM beauty parades in the last year,\u201d says Kieron Scrutton, senior vice president of global medical affairs digital and technology, and tech governance risk and compliance. \u201cThe broader team has been entirely focused on the digital data and AI transformation that we\u2019re making in GSK.\u201d<\/p>\n<div class=\"leading-quote leading-quote--inline leading-quote--inline-in-content\">\n<div class=\"leading-quote__inner\">\n<p>&#8220;We wanted to move fast and be in a position to leverage the innovations and new capabilities in Vault CRM to achieve our business goals.&#8221;<\/p>\n<div class=\"content-leading-quote__author\">\n<h6>Sujatha Chinnappa<\/h6>\n<p>Global Vice President, Commercial Technology, Engineering, and Data, GSK<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p><strong>Watch now<\/strong>: Learn how GSK is building its future of digital and AI with ³Ô¹Ï±¬ÁÏ Vault CRM.<\/p>\n<script>\n\t\t\twindow._wq = window._wq || [];\n\t\t\t_wq.push({\n\t\t\t  id: \"mkkkwf11w8\",\n\t\t\t  options: {\n\t\t\t\tplugin: {\n\t\t\t\t  \"captions\": {\n\t\t\t\t\tonByDefault: true,\n\t\t\t\t\tlanguage: \"ang\" \/\/ ang - English, fre - French, ger - German, ita - Italian, spa - Spanish\n\t\t\t\t  }\n\t\t\t\t}\n\t\t\t  }\n\t\t\t});\n\t\t\t<\/script><script src=\"https:\/\/fast.wistia.com\/embed\/medias\/mkkkwf11w8.jsonp\" async><\/script><script src=\"https:\/\/fast.wistia.com\/assets\/external\/E-v1.js\" async><\/script><div class=\"wistia_responsive_padding\" style=\"padding:56.25% 0 0 0;position:relative;\"><div class=\"wistia_responsive_wrapper\" style=\"height:100%;left:0;position:absolute;top:0;width:100%;\"><div class=\"wistia_embed wistia_async_mkkkwf11w8 videoFoam=true\" style=\"height:100%;position:relative;width:100%\"><div class=\"wistia_swatch\" style=\"height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;\"><img decoding=\"async\" src=\"https:\/\/fast.wistia.com\/embed\/medias\/mkkkwf11w8\/swatch\" style=\"filter:blur(5px);height:100%;object-fit:contain;width:100%;\" alt=\"\" aria-hidden=\"true\" onload=\"this.parentNode.style.opacity=1;\" \/><\/div><\/div><\/div><\/div>\n<h2>Bayer: Achieving zero field downtime in U.S. Vault CRM migration<\/h2>\n<p>The Bayer U.S. team is preparing for multiple launches through 2027, each representing an opportunity to deliver a transformative therapy or new indication for patients. This critical period might not seem ideal for a technology migration. But as a steadfast industry leader, the company was ready to move from a system of records to one of insights. As a result, Bayer is among the first top 20 large life sciences companies to migrate to Vault CRM in the U.S.<\/p>\n<p>\u201cOur idea was to create a customer insights platform, and Vault CRM is the foundation for that. Obviously now is the time to enrich it with more powerful information, with more powerful tools like AI agents,\u201d says Alexander Alex, head of ³Ô¹Ï±¬ÁÏ Platform, Bayer. And with better integration of data in Vault CRM, and by connecting commercial with clinical teams, he says it will be easier to identify new business opportunities and create more consistent customer experiences.<\/p>\n<p>The goal was to migrate to Vault CRM quickly, without immediately introducing all new capabilities, to minimize disruption to the field force and fast-track access to AI and CRM advancements. \u201cWe&#8217;ve seen the innovation and capabilities with Vault CRM and want to make sure we have early access,\u201d says Patrick Salonis, senior director, business systems and operations, Bayer.<\/p>\n<p>Bayer\u2019s global, U.S., and local teams, along with ³Ô¹Ï±¬ÁÏ partners, collaborated to stay focused on the common objectives. Rounding out their strategy: a robust communication, change management, and training program for end users to make the migration as seamless an experience as possible.<\/p>\n<p>\u201cFrom the start, you need transparency and buy-in from the markets so they clearly understand the innovation to come, which will help the field force in their interactions with the physicians,\u201d says Isabela Pimenta, PM &#8211; ³Ô¹Ï±¬ÁÏ CRM to Vault CRM Migration, Bayer. Otherwise, they may see the migration as just another project. \u201cThe entire team understood this as a priority and that we had to get it right the first time,\u201d she adds. This mindset helped drive the migration forward and remain on time.<\/p>\n<p>\u201cI had confidence in the team behind it, both on the Bayer side and on the ³Ô¹Ï±¬ÁÏ side, that we were going to do this right and it wasn&#8217;t going to disrupt any of our critical launches,\u201d says Paul Bedard, senior vice president of customer engagement at Bayer. Looking ahead, Bayer will seek to replicate their U.S. migration success and hone the process for migrations in all other countries where Bayer has a presence.<\/p>\n<div class=\"leading-quote leading-quote--inline leading-quote--inline-in-content\">\n<div class=\"leading-quote__inner\">\n<p>&#8220;We were able to deliver on time without delay on the migration and without taking our U.S. team off the field for even one day. This stood out because it was a big project with a big impact for our field force.&#8221;<\/p>\n<div class=\"content-leading-quote__author\">\n<h6>Isabela Pimenta<\/h6>\n<p>Project Manager, Vault CRM Migration, Bayer<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p><strong>Watch the highlights<\/strong>: See how Bayer&#8217;s U.S. teams achieved a seamless Vault CRM migration with zero business disruption.<\/p>\n<script>\n\t\t\twindow._wq = window._wq || [];\n\t\t\t_wq.push({\n\t\t\t  id: \"c2qf75ybnl\",\n\t\t\t  options: {\n\t\t\t\tplugin: {\n\t\t\t\t  \"captions\": {\n\t\t\t\t\tonByDefault: true,\n\t\t\t\t\tlanguage: \"ang\" \/\/ ang - English, fre - French, ger - German, ita - Italian, spa - Spanish\n\t\t\t\t  }\n\t\t\t\t}\n\t\t\t  }\n\t\t\t});\n\t\t\t<\/script><script src=\"https:\/\/fast.wistia.com\/embed\/medias\/c2qf75ybnl.jsonp\" async><\/script><script src=\"https:\/\/fast.wistia.com\/assets\/external\/E-v1.js\" async><\/script><div class=\"wistia_responsive_padding\" style=\"padding:56.25% 0 0 0;position:relative;\"><div class=\"wistia_responsive_wrapper\" style=\"height:100%;left:0;position:absolute;top:0;width:100%;\"><div class=\"wistia_embed wistia_async_c2qf75ybnl videoFoam=true\" style=\"height:100%;position:relative;width:100%\"><div class=\"wistia_swatch\" style=\"height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;\"><img decoding=\"async\" src=\"https:\/\/fast.wistia.com\/embed\/medias\/c2qf75ybnl\/swatch\" style=\"filter:blur(5px);height:100%;object-fit:contain;width:100%;\" alt=\"\" aria-hidden=\"true\" onload=\"this.parentNode.style.opacity=1;\" \/><\/div><\/div><\/div><\/div>\n<h2>Drive productivity with AI in Vault CRM and intelligence-driven engagement <\/h2>\n<p>AI in Vault CRM\u2019s value is in tackling industry-specific tasks and activities \u2014 which requires the deepest understanding of life sciences. The featured companies and many others have chosen to focus their efforts on customers and patients.<\/p>\n<p>With AI in Vault CRM, these leaders will increase productivity and achieve orchestrated, customer-centric engagement across data, content, and teams. Their investment is secure with a proven partner, safeguarding their mission to benefit patients long into the future.<\/p>\n<p><strong><a href=\"\/eu\/resources\/veeva-ai-for-vault-crm\/\">Explore AI in Vault CRM<\/a><\/strong>: Fast-track personalized engagement and elevate your commercial execution.<\/p>\n<p><footnotes><\/p>\n<hr>\n<p><sup>1<\/sup> ³Ô¹Ï±¬ÁÏ Pulse data, Q2 2024 <br \/>\n<sup>2<\/sup> ³Ô¹Ï±¬ÁÏ Pulse data, Q2 2025 <br \/>\n<\/footnotes><\/p>\n","protected":false},"excerpt":{"rendered":"<p>These top biopharma leaders chose Vault CRM to advance commercial excellence and gain an edge with embedded, industry-specific ³Ô¹Ï±¬ÁÏ AI agents. Read about their migrations.<\/p>\n","protected":false},"featured_media":89421,"parent":0,"template":"","class_list":["post-89419","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-20-ai","resource-area-20-commercial","resource-product-20-ai-vault-ai","resource-product-20-crm","resource-type-white-papers"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/89419"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/89419\/revisions"}],"predecessor-version":[{"id":97936,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/89419\/revisions\/97936"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/89421"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=89419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}